RKIP inhibits the malignant phenotypes of gastric cancer cells

Neoplasma

Volumn 60, Issue 2, 2013, Pages 196-202

  Zhang, X M ^a   Gu, H ^a   Yan, L ^a   Zhang, G Y ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Gastric cancer; Raf; RKIP; SGC7901; Tumor suppressor

Indexed keywords

COMPLEMENTARY DNA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PEBP1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL ASSAY; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; MOUSE; NICK END LABELING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TRANSWELL INVASION ASSAY; WESTERN BLOTTING; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84876727188     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_026     Document Type: Article

References (19)

1. LEUNG WK, WU MS, KAKUGAWA Y, KIM JJ, YEOH KG, et al. Screening for gastric cancer in Asia:current evidence and practice. Lancet Oncol 2008; 9: 279-287 http://dx.doi.org/10.1016/S1470-2045(08)70072-X
2. OOI CH, IVANOVA T, WU J, LEE M, TAN IB, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 2009; 5: e1000676. http://dx.doi.org/10.1371/journal.pgen.1000676
3. YUAN W, CHEN Z, CHEN Z, WU S, GUO J, et al. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo. Neoplasma 2012; 59: 105-113. http://dx.doi.org/10.4149/neo_2012_014
4. DAI L, CHENG L, ZHANG X, JIANG Q, ZHANG S, et al. Plasmid-based STAT3-siRNA efficiently inhibits breast tumor growth and metastasis in mice. Neoplasma 2011; 58: 538-547. http://dx.doi.org/10.4149/neo_2011_06_538
5. HUANG C, YANG G, JIANG T, ZHU G, LI H, et al. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma 2011; 58: 396-405. http://dx.doi.org/10.4149/neo_2011_05_396
6. KELLER ET. Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP). Anticancer Drugs 2004; 15: 663-669. http://dx.doi.org/10.1097/01.cad.0000136877.89057.b9
7. YEUNG K, SEITZ T, LI S, JANOSCH P, MCFERRAN B, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401: 173-177. http://dx.doi.org/10.1038/43686
8. ESCARA-WILKE J, YEUNG K, KELLER ET. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012 Jun 9. [Epub ahead of print] http://dx.doi.org/10.1007/s10555-012-9365-9
9. ZHANG ZQ, LI MY, ZHANG GY, PENG F, YAO HX, et al. Quantitative proteome analysis of clinical gastric adenocarcinoma using 18O stable isotope laeling and LCM. Prog. Biochem. Biophys 2009, 36(3): 311-322. http://dx.doi.org/10.3724/SP.J.1206.2008.00400
10. MCCUBREY JA, STEELMAN LS, CHAPPELL WH, ABRAMS SL, WONG EW, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007, 1773: 1263-1284.
11. LI HZ, GAO Y, ZHAO XL, LIU YX, SUN BC, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 2009; 7: 832-840. http://dx.doi.org/10.1158/1541-7786.MCR-08-0403
12. ZLOBEC I, BAKER K, MINOO P, JASS JR, TERRACCIANO L, et al. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph nodestatus, vascular invasion, and raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008, 14: 143-148. http://dx.doi.org/10.1158/1078-0432.CCR-07-1380
13. NOTARBARTOLO M, GIANNITRAPANI L, VIVONA N, POMA P, LABBOZZETTA M, et al. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. OMICS 2011; 15: 267-272. http://dx.doi.org/10.1089/omi.2010.0096
14. LI HZ, WANG Y, GAO Y, SHAO J, ZHAO XL, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008; 6: 917-928. http://dx.doi.org/10.1158/1541-7786.MCR-08-0093
15. WANG J, YANG YH, WANG AQ, YAO B, XIE G, et al. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 2010, 27: 219-223. http://dx.doi.org/10.1007/s12032-009-9194-z
16. FUJIMORI Y, INOKUCHI M, TAKAGI Y, KATO K, KOJIMA K, et al. Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res 2012 Mar 31; 31: 30. http://dx.doi.org/10.1186/1756-9966-31-30
17. CHATTERJEE D, BAI Y, WANG Z, BEACH S, MOTT S, et al. RKIP sensitizes prostate and breast cancer cells to druginduced apoptosis. J Biol Chem 2004; 279: 17515-17523. http://dx.doi.org/10.1074/jbc.M313816200
18. PARK S, YEUNG ML, BEACH S, SHIELDS JM, YEUNG KC. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 2005; 24: 3535-3540. http://dx.doi.org/10.1038/sj.onc.1208435
19. DANGI-GARIMELLA S, YUN J, EVES EM, NEWMAN M, ERKELAND SJ, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009; 28: 347-358. http://dx.doi.org/10.1038/emboj.2008.294